NATIONAL

More news
Aduhelm, Biogen's controversial recently approved drug for early Alzheimer's disease, is seen at Butler Hospital, one of the clinical research sites in Providence, Rhode Island, U.S. June 16, 2021. Jessica Rinaldi/Pool via REUTERS

U.S. Medicare Limits Coverage For Biogen's Alzheimer's Drug

The U.S. government health plan for people age 65 and over on Thursday issued its final coverage policy for Biogen Inc's Alzheimer's drug, Aduhelm, moving forward with an unusually strict plan limiting it to patients in clinical trials.
An American flag waves outside the U.S. Department of Justice Building in Washington, U.S., December 15, 2020.

Four U.S. Secret Service Agents Suspended Over Ties To Phony Cops

The U.S. Secret Service has suspended four agents linked to two men accused of impersonating federal law enforcement officers who authorities said gave gifts worth thousands of dollars to agency personnel including one assigned to protect President Joe Biden's wife.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.